Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Cancer|October 28, 2020
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survivalJohannes Thurmaier, Volker Heinemann, Jutta Engel, et al.Anti-Cancer Drugs|June 6, 2017
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancerArndt Stahler, Volker Heinemann, Jens Neumann, et al.European Journal of Cancer (Oxford, England : 1990)|March 1, 2021
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110)Kathrin Heinrich, Dominik P Modest, Ingrid Ricard, et al.European Journal of Cancer (Oxford, England : 1990)|August 19, 2020
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trialArndt Stahler, Sebastian Stintzing, Jobst C von Einem, et al.Cancers|July 27, 2022
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEALJörg Kumbrink, Lisa Bohlmann, Soulafa Mamlouk, et al.International Journal of Cancer|August 25, 2021
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)Lian Liu, Nicole Tonya Erickson, Ingrid Ricard, et al.Pageof 4